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itral Stenosis: When Is it Useful?*
elvin D. Cheitlin, MD, MACC
an Francisco, California
f all valve lesions, mitral stenosis has the most options for
ntervention and in many ways is the valve lesion where it is
asiest to make a decision that intervention is necessary.
his was the first acquired valve lesion where patient
ymptoms and ultimate prognosis could be improved surgi-
ally even before cardiopulmonary bypass was available. The
ndications for the timing of valve repair or replacement are
ell presented in the American College of Cardiology/
merican Heart Association guidelines for the management
f patients with valvular heart disease (1). Intervention is
ecommended in symptomatic patients (New York Heart
ssociation [NYHA] class II, III, and IV) with mitral
tenosis and a mitral valve area of1.5 cm (2). Intervention
See page 393
s also indicated in patients with a similar valve area and
ulmonary hypertension (pulmonary artery systolic pressure
f 50 mm Hg at rest, 60 mm Hg with exercise). In a
ymptomatic patient, the presence of left atrial thrombus
nd/or 3 to 4 mitral regurgitation is a contraindication to
alloon valvotomy. The presence of a thrombus that does
ot lyse with several months of anticoagulation in an
therwise-favorable valve is an indication for open mitral
alve repair. The presence of heavy calcification, marked
ubvalvular obstruction, and/or 3 to 4 mitral regurgitation
s an indication for valve replacement. Because the mortality
nd late morbidity are higher in valve replacement than in
alve repair, the patient should be symptomatic despite
edical management, at least NYHA class III, before valve
eplacement is recommended.
For a long time it has been recognized that patients can
ave severe mitral stenosis and yet be asymptomatic, al-
hough this state does not usually last long. Conversely, a
atient can have mitral stenosis that objectively ought to be
ild, with valve areas 1.5 cm2, and be quite symptomatic.
*Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the University of California, San Francisco, and the San Francisco Generaldospital, San Francisco, California.t is these patients where there is a need to evaluate beyond
history, physical examination, and a resting echo Doppler.
ymptoms of dyspnea at rest or on exertion, orthopnea, and
aroxysmal nocturnal dyspnea can be related to either
edically treatable hemodynamic changes with mitral ste-
osis or to concomitant diseases, such as chronic obstructive
ulmonary disease or coronary artery disease. To better
valuate such patients, measurement of the hemodynamics
uring exercise, in the past by catheterization and more
ecently by Doppler echocardiography, has been used.
To understand how exercise can help to sort out these
roblems, the hemodynamics in mitral stenosis that result in
he symptoms of dyspnea on exertion, orthopnea, and
aroxysmal nocturnal dyspnea must be reviewed. In mitral
tenosis these symptoms depend on the elevation of the left
trial, pulmonary venous, and pulmonary capillary pressure
o a level where neural receptors that stimulate the sensation
f dyspnea are activated and also to levels where the
ulmonary capillary pressure overcomes the colloid osmotic
ressure in the blood, resulting in a net flow of fluid out of
he capillaries into the pulmonary interstitium. In addition
o left atrial pressure increase, atrial fibrillation with rapid
entricular response is frequently the first precipitator of
ymptoms.
A second hemodynamic reason for these signs and
ymptoms is the development of pulmonary hypertension
nd secondary afterload on the right ventricle. In most
atients, the rise in pulmonary artery pressure is passive, an
levation secondary to the elevated pressure in the left
trium, without a change in pulmonary vascular resistance.
n 10% to 15% of patients with severe mitral stenosis, there
s a marked rise in pulmonary arteriolar resistance and
ulmonary artery pressure beyond that expected from the
levated left atrial pressure. This increase in pulmonary
rtery pressure places an afterload burden on the right
entricle, resulting in right ventricular hypertrophy, dilation,
nd eventually failure. With right ventricular dilation, in-
reasing tricuspid regurgitation can occur, and with a failing
ight ventricle, the cardiac output (CO) decreases. The
atient now has less shortness of breath and orthopnea and
omplains of decreased exercise tolerance. Finally, the de-
elopment of atrial fibrillation markedly increases the risk of
hrombus formation in the left atrium and subsequent
ystemic embolization.
To address the effect of exercise on the hemodynamic
eterminants of symptoms, the elevated pulmonary capillary
ressure reflected by the left atrial pressure and the de-
reased CO, rearrangement of the elements of the Gorlin
quation for determining valve area is useful.
MVA 
CO
38  DFP LAD LVD
here MVA  mitral valve area, CO  cardiac output,
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rifice area (coefficient of orifice contract) and other factors,
uch as conversion of units.
With rearrangement, the following is observed:
LAD LVD  CO38  DFP MVA
2
With exercise, the CO and heart rate increase, and the
FP decreases. With a fixed mitral valve orifice, there is an
xponential increase in left atrial and pulmonary capillary
ressure. Clearly, the left atrial pressure is determined by
ore than the degree of mitral valve stenosis. Even with
ild mitral stenosis, the left atrial pressure could still
arkedly rise if the heart rate and/or CO increases mark-
dly. Here, decreasing the rise in CO (e.g., correcting
nemia) or preventing an inordinate increase in heart rate
ith exercise by beta-blockers might make the patient
symptomatic.
Exercise is the ideal way to evaluate the symptomatic
atient with only mild-to-moderate mitral stenosis because
his is the activity that usually precipitates the symptoms.
owever, dobutamine, which simulates the effects of exer-
ise by increasing CO and heart rate, is more amenable to
se with echocardiography, because the marked increase in
espiratory activity and chest motion, which makes imaging
ifficult, is absent.
In this issue of the Journal, Reis et al. (2) used dobut-
mine stress Doppler echocardiography (DSE) in evaluating
atients with mitral stenosis, which has been reported in the
ast, to a new level in their prospective follow-up of 53
itral stenosis patients with a wide range of mitral valve
reas, from under 1 cm2 to over 1.5 cm2. Resting hemody-
amics were measured and the mitral valve area measured by
lanimetry. Dobutamine stress Doppler echocardiography
as then performed with hemodynamics again measured at
eak infusion. The patients were followed for a mean of 60
11 months. The clinical end points recorded were: 1)
ospitalization for progressive dyspnea, pulmonary edema,
r complications related to mitral stenosis; 2) surgical or
alloon intervention, a decision made by the patient’s
hysician using conventional indications; 3) atrial or ven-
ricular arrhythmias associated with hemodynamic instabil-
ty requiring urgent cardioversion or hospitalization; and 4)
eath (there were no deaths).
A total of 29 (55%) patients had a clinical end point
uring follow-up, 16 with progressive dyspnea, 6 with atrial
rrhythmias, and 7 with pulmonary edema. They found that
SE was able to best detect those patients who would have
clinical event on follow-up if they used a cutpoint of 18
m Hg mean diastolic gradient with dobutamine stress,
hich was determined by the point where the sensitivity and
pecificity curves crossed. At this level, there was a sensitiv-
ty of 90%, a specificity of 87%, and an overall accuracy of
0%.There are problems with using these excellent results
n applying this strategy to all patients with mitral stenosis.
he study eliminated all patients with NYHA class IV
ymptoms as well as patients with known episodes of
achyarrhythmias associated with hemodynamic insta-
ility, patients with other valve disease, those with
ore than 2 mitral regurgitation, and anyone with
ife-threatening medical conditions. Although they ad-
itted patients with NYHA class III symptoms, all those
atients with a mitral valve area 1 cm2 were considered
or mitral valve surgery after the initial evaluation. They
lso found that in patients with a mitral valve area of
1.5 cm2, 85% of whom had had a previous commissurot-
my, that DSE does not appreciably add to the clinical
valuation and resting echocardiogram. This left only 22
atients with a mitral valve area of 1 to 1.5 cm2. Of those,
nly patients who were NYHA class I or II were the ones in
hom DSE was able to predict future clinical events if the
obutamine stress mean diastolic gradient was 18 mm Hg
r more.
Is there value in performing DSE in patients with
itral stenosis? Certainly those with a mitral valve area
1 cm2 who are class III or IV should have a mitral
ntervention, balloon or repair if possible, and replacement
f necessary. Those who are asymptomatic with a satisfac-
ory lifestyle should be followed, with the exception of
hose with moderate or severe pulmonary hypertension and
hose who can have a repair by balloon valvuloplasty or
urgery.
The clinical end points chosen in this study are valid end
oints in themselves, but it is questionable whether a DSE
s indicated in a relatively asymptomatic patient with mild-
o-moderate mitral stenosis simply to identify a group who
ay sometime in the future develop symptoms to the point
here intervention is deemed appropriate. In this group, it
ould be just as well to wait for increasing symptoms to
ntervene. Only those who developed pulmonary edema, 7
atients (24%) of the 29 who reached end points, would
ave been better served by being identified before this
ccurred because patients with sudden pulmonary edema
ut of the hospital have a life-threatening complication. If
his could be prevented by previous intervention, certainly
hese seven patients, 13% of the entire group, would have
enefited by previous risk stratification by DSE.
Dobutamine stress Doppler echocardiography is most
seful where we used catheterization with exercise in the
ast: in those patients with symptoms not explainable by the
alculated valve area, where a rise in mean mitral valve
radient to 18 mm Hg or above is consistent with a patient
hose symptoms are due to obstruction to flow and who
ould benefit from mitral valve intervention. Therefore, it
ppears that the role for DSE is not so much in predicting
he asymptomatic or minimally symptomatic patient who












404 Cheitlin JACC Vol. 43, No. 3, 2004
Editorial Comment February 4, 2004:402–4atients with symptoms out of proportion to the severity of
heir calculated mitral valve area who will most probably
enefit from an intervention that may be either medical or
nvasive.
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